- Home
- CCCC vs FTK Comparison
CCCC vs FTK Comparison
Compare CCCC & FTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- FTK
- Stock Information
- Founded
- CCCC 2015
- FTK 1985
- Country
- CCCC United States
- FTK United States
- Employees
- CCCC N/A
- FTK N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- FTK Major Chemicals
- Sector
- CCCC Health Care
- FTK Industrials
- Exchange
- CCCC Nasdaq
- FTK Nasdaq
- Market Cap
- CCCC 244.9M
- FTK 244.9M
- IPO Year
- CCCC 2020
- FTK N/A
- Fundamental
- Price
- CCCC $3.01
- FTK $8.23
- Analyst Decision
- CCCC Buy
- FTK Strong Buy
- Analyst Count
- CCCC 5
- FTK 2
- Target Price
- CCCC $11.60
- FTK $7.50
- AVG Volume (30 Days)
- CCCC 1.8M
- FTK 202.3K
- Earning Date
- CCCC 03-04-2025
- FTK 03-10-2025
- Dividend Yield
- CCCC N/A
- FTK N/A
- EPS Growth
- CCCC N/A
- FTK N/A
- EPS
- CCCC N/A
- FTK 0.27
- Revenue
- CCCC $33,668,000.00
- FTK $178,455,000.00
- Revenue This Year
- CCCC $75.59
- FTK N/A
- Revenue Next Year
- CCCC N/A
- FTK $13.93
- P/E Ratio
- CCCC N/A
- FTK $30.29
- Revenue Growth
- CCCC 65.45
- FTK N/A
- 52 Week Low
- CCCC $2.79
- FTK $2.64
- 52 Week High
- CCCC $11.88
- FTK $10.35
- Technical
- Relative Strength Index (RSI)
- CCCC 33.55
- FTK 41.53
- Support Level
- CCCC $2.79
- FTK $8.51
- Resistance Level
- CCCC $3.38
- FTK $9.55
- Average True Range (ATR)
- CCCC 0.20
- FTK 0.42
- MACD
- CCCC -0.03
- FTK -0.08
- Stochastic Oscillator
- CCCC 23.66
- FTK 1.12
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven company focused on reducing the environmental impact of energy operations. Its Chemistry Technologies segment develops green specialty chemicals to enhance the profitability of hydrocarbon producers, catering to major players in the oil and gas industry. These chemicals improve operational efficiency and sustainability throughout the well life cycle. The Data Analytics segment provides real-time analytics for hydrocarbon streams, enabling users to optimize processes and increase profitability by reducing waste and reprocessing. Flotek's revenue primarily comes from its Chemistry segment, reflecting its commitment to providing solutions for environmental improvement in the energy sector.